Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension
- PMID: 1345893
- DOI: 10.1097/00000441-199201000-00006
Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension
Abstract
A 72-year-old woman with 5-year history of essential hypertension developed peritoneal tuberculosis. The patient's hypertension, which had been well-controlled by long-acting nifedipine, deteriorated after the administration of rifampicin, an antitubercular agent. During use of nifedipine and rifampicin, both the peak plasma concentration and the area under the curve of nifedipine decreased markedly to about 40% of those without rifampicin. The findings suggest that rifampicin may increase the elimination of nifedipine, presumably by induction of its hepatic metabolism. Nisoldipine, another calcium antagonist, also failed to lower the patient's blood pressure, when given in combination with rifampicin. Taken together, these findings indicate that more caution should be urged when calcium antagonist is prescribed along with rifampicin.
Similar articles
-
[Influence of rifampicin on antihypertensive effects of dihydropiridine calcium-channel blockers in four elderly patients].Nihon Ronen Igakkai Zasshi. 1996 Sep;33(9):692-6. doi: 10.3143/geriatrics.33.692. Nihon Ronen Igakkai Zasshi. 1996. PMID: 8940868 Japanese.
-
A case of variant angina exacerbated by administration of rifampicin.Heart Vessels. 1987;3(4):214-7. doi: 10.1007/BF02058314. Heart Vessels. 1987. PMID: 3453828
-
[Urinary bladder tuberculosis and Bacillus Calmette-Guérin instillation: reduced efficacy of bisoprolol in hypertension].Dtsch Med Wochenschr. 2010 Oct;135(40):1968-70. doi: 10.1055/s-0030-1263343. Epub 2010 Oct 4. Dtsch Med Wochenschr. 2010. PMID: 20922637 German.
-
A review of calcium channel antagonists in the treatment of pediatric hypertension.Paediatr Drugs. 2006;8(6):357-73. doi: 10.2165/00148581-200608060-00004. Paediatr Drugs. 2006. PMID: 17154643 Review.
-
Current treatment of patients with hypertension: therapeutic implications of INSIGHT.Drugs. 2003;63(14):1435-44. doi: 10.2165/00003495-200363140-00001. Drugs. 2003. PMID: 12834362 Review.
Cited by
-
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.Clin Pharmacokinet. 2001;40(11):833-68. doi: 10.2165/00003088-200140110-00004. Clin Pharmacokinet. 2001. PMID: 11735605 Review.
-
Calcium antagonists. Drug interactions of clinical significance.Drug Saf. 1995 Sep;13(3):157-87. doi: 10.2165/00002018-199513030-00003. Drug Saf. 1995. PMID: 7495502 Review.
-
Pharmacokinetic interactions with rifampicin : clinical relevance.Clin Pharmacokinet. 2003;42(9):819-50. doi: 10.2165/00003088-200342090-00003. Clin Pharmacokinet. 2003. PMID: 12882588 Review.
-
Rifampicin and anti-hypertensive drugs in chronic kidney disease: Pharmacokinetic interactions and their clinical impact.Indian J Nephrol. 2016 Sep;26(5):322-328. doi: 10.4103/0971-4065.176145. Indian J Nephrol. 2016. PMID: 27795624 Free PMC article.
-
Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine.Br J Clin Pharmacol. 2019 Apr;85(4):737-745. doi: 10.1111/bcp.13848. Epub 2019 Jan 30. Br J Clin Pharmacol. 2019. PMID: 30589098 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical